Stocks of Sage Therapeutics Inc (NASDAQ:SAGE) traded higher last session on Wall Street, up 0.47% to $19.43.
As we calculate the median target price by taking the range between a high of $79.00 and a low of $18.00, we find $22.00. Given the previous closing price of $19.34, this indicates a potential upside of 13.75 percent. SAGE stock price is now -0.48% away from the 50-day moving average and -46.40% away from the 200-day moving average. The market capitalization of the company currently stands at $1.17B.
Brokers who have rated the stock have averaged $25.50 as their price target over the next twelve months.
In other news, Barrett Elizabeth, Director bought 2,000 shares of the company’s stock on Aug 09. The stock was bought for $37,279 at an average price of $18.64. Upon completion of the transaction, the Director now directly owns 3,000 shares in the company, valued at $58290.0. An SEC document containing details of the transaction can be found on the SEC’s website. On May 09, Director Barrett Elizabeth bought 1,000 shares of the business’s stock. A total of $50,500 was incurred on buying the stock at an average price of $50.50. This leaves the insider owning 1,000 shares of the company worth $19430.0. Insiders disposed of 18,210 shares of company stock worth roughly $0.35 million over the past 1 year. A total of 14.13% of the company’s stock is owned by insiders.
Wednesday’s opening bell rang with an opening price of $19.60 for Sage Therapeutics Inc (NASDAQ: SAGE). During the past 12 months, Sage Therapeutics Inc has had a low of $16.51 and a high of $59.99. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 7.02, and a quick ratio of 7.02. The fifty day moving average price for SAGE is $19.52 and a two-hundred day moving average price translates $36.25 for the stock.
The latest earnings results from Sage Therapeutics Inc (NASDAQ: SAGE) was released for Sep, 2023. According to the Biotechnology Company, earnings per share came in at -$3.37, missing analysts’ expectations of -$2.73 by -0.64. This compares to -$2.31 EPS in the same period last year. The net profit margin was -5779.62% and return on equity was -59.72% for SAGE. The company reported revenue of $2.72 million for the quarter, compared to $1.74 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 56.18 percent. For the current quarter, analysts expect SAGE to generate $70.5M in revenue.
